Erebra tablets sublingual 0.02 g. №20

Description

Erebra Storage
active substance: hyporamine dry extract (sea buckthorn buckthorn leaves dry extract, Hippophae rhamnoides L.) (6.5: 1), ethanol extractant – 70%) with the content of tannins in terms of casuarinin and absolutely dry matter 60%);

1 tablet contains hyporamine dry extract 20 mg;

Excipients: sucrose, cocoa powder (cocoa beans powder), vanillin, carmellose sodium, calcium stearate.

Erebra Dosage form
tablets are round, biconvex, with a line, from light gray or light gray with a pink tinge to light brown with darker and lighter spots.

Pharmacotherapeutic group
Other antiviral drugs. ATX code J05A X.

Pharmacological properties
Hyporamine ̶ dry purified extract from the leaves of sea buckthorn (Hippophae rhamnoides L.) ̶ is a polyphenolic complex of haloelagotanins, the biologically active components of which are hydrolyzed tannins, which have common structural elements in the form of glucose-haloal and hexahydroxyphenol.

Hyporamine shows high antiviral activity against various strains of influenza A and B viruses, adenoviruses, paramyxoviruses, herpes simplex viruses, shingles, cytomegalovirus (CMV), respiratory syncytial virus (PC virus). The inhibitory effect of the drug on the reproduction of viruses is manifested in the early stages of their development. One of the mechanisms of action of the drug is the inhibitory effect on viral neuraminidase.

Hyporamine induces the production of interferon in blood cells in vitro and increases the content of interferon in the blood of patients.

The in vitro drug also has a moderate antimicrobial effect against gram-positive (Staphylococcus aureus) and gram-negative bacteria (Escherichia coli, Proteus vulgaris, Pseudomonas aeruginosa), tuberculous mycobacteria (Mycobacterium tuberculosis), Candida candidiasis (Candida).

Erebra Indication
As a therapeutic and prophylactic agent for influenza (A and B), parainfluenza, respiratory syncytial viral, viral, adenoviral and other acute respiratory viral infections; sore throats occurring on the background of acute respiratory viral diseases (complex therapy); in acute and recurrent forms of herpes simplex of extragenital and genital localization, shingles, chickenpox and cytomegalovirus infection.

Contraindication
Hypersensitivity to the components of the drug. Sucrase / isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption.

Interaction with other medicinal products and other forms of interaction
It is possible to use the drug in combination with other drugs (antimicrobials, synthetic antivirals, drugs for symptomatic therapy).

Features of application
It should be prescribed at the earliest stages of the disease.

Use with caution in diabetes.

1 tablet of the drug contains 0.5539 g of carbohydrates, which corresponds to 0.046 HO. Patients with diabetes should take the drug only after consulting a doctor.